Masahiro Hiruta

Papers

Total Citations

H-Index

About

Masahiro Hiruta is a dedicated researcher in urologic oncology, with a particular focus on prostate cancer prognosis and treatment outcomes. His work centers on identifying histopathological and clinical factors that predict biochemical recurrence, especially in patients undergoing radical prostatectomy and subsequent salvage radiotherapy. Hiruta’s major contribution lies in elucidating the prognostic significance of the cribriform pattern—a specific histological architecture—as a predictive factor for PSA recurrence after radiotherapy. This finding has important implications for risk stratification and personalized treatment planning in prostate cancer management. With over 2 citations to his most recent work, Hiruta’s research is gaining recognition among clinicians and pathologists seeking to refine post-surgical surveillance and therapeutic decision-making. His studies bridge the gap between surgical pathology and radiation oncology, offering actionable insights that may help reduce recurrence rates and improve patient outcomes. By highlighting the role of cribriform morphology in treatment response, Hiruta has made a notable contribution to the evolving understanding of prostate cancer biology and its clinical course.